The topical pain relief market size has grown strongly in recent years. It will grow from $11.42 billion in 2025 to $12.04 billion in 2026 at a compound annual growth rate (CAGR) of 5.4%. The growth in the historic period can be attributed to rising prevalence of musculoskeletal disorders, increased incidence of sports and lifestyle injuries, widespread availability of otc pain relief products, growing aging population, expansion of pharmacy retail networks.
The topical pain relief market size is expected to see strong growth in the next few years. It will grow to $14.88 billion in 2030 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to increasing adoption of self-care pain management, rising demand for opioid-free alternatives, expansion of e-commerce pharmaceutical sales, growing focus on chronic pain management, increasing innovation in topical drug delivery. Major trends in the forecast period include increasing demand for non-opioid topical analgesics, rising preference for over-the-counter pain relief products, expansion of advanced transdermal delivery systems, increased use of combination formulations, enhanced focus on fast-acting and long-lasting relief.
The increasing prevalence of arthritis and bone-related disorders is expected to drive the growth of the topical pain relief market in the coming years. Arthritis and bone-related disorders include medical conditions that affect the joints, bones, and surrounding tissues. Topical pain relief is commonly used to manage these conditions by alleviating localized pain, inflammation, and discomfort, particularly in superficial joints. For example, in August 2024, Healthy Bones Australia, an Australia-based non-profit organization, reported that in 2023, 6.2 million Australians aged 50 and over had poor bone health, with 77% affected by osteopenia and 23% by osteoporosis, and this number is projected to increase to 7.7 million by 2033. Therefore, the growing prevalence of arthritis and bone-related disorders is supporting the growth of the topical pain relief market.
Leading companies in the topical pain relief market are focusing on developing innovative products, such as pain-relieving creams, to meet the rising demand for effective pain management solutions. Pain-relieving cream is a topical formulation that provides penetrating relief to numb minor joint and muscle soreness. For example, in August 2023, Kenvue Inc., a US-based consumer health company, launched a new topical pain-relieving cream called Tylenol, formulated to deliver maximum-strength lidocaine (4%) without a prescription. The product is available in two formats: a rapid-absorbing formula and a uniquely designed rollerball for hands-free, no-mess application. It is fragrance-free and comes in fresh scent options for discreet use. Additionally, the cream provides targeted and rapid pain relief, catering to consumers seeking effective and convenient solutions.
In December 2023, Wellnex Life Limited, an Australia-based health and wellness company, acquired Painaway Australia Pty Ltd. for $13.6 million. Through this acquisition, Wellnex Life Limited aims to significantly expand its wholly-owned brand portfolio in the topical pain relief segment while materially strengthening the company. Painaway Australia Pty Ltd. is an Australia-based manufacturer specializing in topical pain relief products.
Major companies operating in the topical pain relief market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., GlaxoSmithKline Plc, Eli Lilly and Company, Reckitt Benckiser Group plc, Viatris Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Limited, Cipla Ltd., Lupin Limited, Almirall S.A., AdvaCare Pharma, Topical BioMedics Inc.
North America was the largest region in the topical pain relief market in 2025. The regions covered in the topical pain relief market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the topical pain relief market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the topical pain relief market by increasing costs of imported active ingredients, excipients, packaging materials, and transdermal patch components used in creams, gels, sprays, and patches. Manufacturers in North America and Europe are most affected due to reliance on global ingredient sourcing, while Asia-Pacific faces export cost pressures for finished formulations. These tariffs are contributing to higher production costs and pricing adjustments. However, they are also encouraging localized manufacturing, regional ingredient sourcing, and innovation in cost-efficient formulation technologies.
The topical pain relief market research report is one of a series of new reports that provides topical pain relief market statistics, including topical pain relief industry global market size, regional shares, competitors with a topical pain relief market share, detailed topical pain relief market segments, market trends and opportunities, and any further data you may need to thrive in the topical pain relief industry. This topical pain relief market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Topical pain relief refers to analgesic medications applied directly to the skin or mucous membranes to reduce pain. These products provide targeted relief by delivering active ingredients to the specific area of pain or inflammation. They are commonly used for muscle aches, joint pain, arthritis, and injuries.
The main categories of topical pain relief include prescription pain relief and over-the-counter (OTC) pain relief. Prescription pain relief consists of medications or treatments that require a healthcare professional’s authorization. These are available in various forms, including creams, gels, sprays, patches, and more. They are used in both non-opioid and opioid therapies and are distributed through pharmacies, drug stores, e-commerce platforms, retail outlets, and grocery stores.
The topical pain relief market consists of sales of such as lotions, instant relief creams, roll-ons, pumps of lotion, analgesic creams, powders and rubs. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The topical pain relief market size is expected to see strong growth in the next few years. It will grow to $14.88 billion in 2030 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to increasing adoption of self-care pain management, rising demand for opioid-free alternatives, expansion of e-commerce pharmaceutical sales, growing focus on chronic pain management, increasing innovation in topical drug delivery. Major trends in the forecast period include increasing demand for non-opioid topical analgesics, rising preference for over-the-counter pain relief products, expansion of advanced transdermal delivery systems, increased use of combination formulations, enhanced focus on fast-acting and long-lasting relief.
The increasing prevalence of arthritis and bone-related disorders is expected to drive the growth of the topical pain relief market in the coming years. Arthritis and bone-related disorders include medical conditions that affect the joints, bones, and surrounding tissues. Topical pain relief is commonly used to manage these conditions by alleviating localized pain, inflammation, and discomfort, particularly in superficial joints. For example, in August 2024, Healthy Bones Australia, an Australia-based non-profit organization, reported that in 2023, 6.2 million Australians aged 50 and over had poor bone health, with 77% affected by osteopenia and 23% by osteoporosis, and this number is projected to increase to 7.7 million by 2033. Therefore, the growing prevalence of arthritis and bone-related disorders is supporting the growth of the topical pain relief market.
Leading companies in the topical pain relief market are focusing on developing innovative products, such as pain-relieving creams, to meet the rising demand for effective pain management solutions. Pain-relieving cream is a topical formulation that provides penetrating relief to numb minor joint and muscle soreness. For example, in August 2023, Kenvue Inc., a US-based consumer health company, launched a new topical pain-relieving cream called Tylenol, formulated to deliver maximum-strength lidocaine (4%) without a prescription. The product is available in two formats: a rapid-absorbing formula and a uniquely designed rollerball for hands-free, no-mess application. It is fragrance-free and comes in fresh scent options for discreet use. Additionally, the cream provides targeted and rapid pain relief, catering to consumers seeking effective and convenient solutions.
In December 2023, Wellnex Life Limited, an Australia-based health and wellness company, acquired Painaway Australia Pty Ltd. for $13.6 million. Through this acquisition, Wellnex Life Limited aims to significantly expand its wholly-owned brand portfolio in the topical pain relief segment while materially strengthening the company. Painaway Australia Pty Ltd. is an Australia-based manufacturer specializing in topical pain relief products.
Major companies operating in the topical pain relief market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., GlaxoSmithKline Plc, Eli Lilly and Company, Reckitt Benckiser Group plc, Viatris Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Limited, Cipla Ltd., Lupin Limited, Almirall S.A., AdvaCare Pharma, Topical BioMedics Inc.
North America was the largest region in the topical pain relief market in 2025. The regions covered in the topical pain relief market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the topical pain relief market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the topical pain relief market by increasing costs of imported active ingredients, excipients, packaging materials, and transdermal patch components used in creams, gels, sprays, and patches. Manufacturers in North America and Europe are most affected due to reliance on global ingredient sourcing, while Asia-Pacific faces export cost pressures for finished formulations. These tariffs are contributing to higher production costs and pricing adjustments. However, they are also encouraging localized manufacturing, regional ingredient sourcing, and innovation in cost-efficient formulation technologies.
The topical pain relief market research report is one of a series of new reports that provides topical pain relief market statistics, including topical pain relief industry global market size, regional shares, competitors with a topical pain relief market share, detailed topical pain relief market segments, market trends and opportunities, and any further data you may need to thrive in the topical pain relief industry. This topical pain relief market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Topical pain relief refers to analgesic medications applied directly to the skin or mucous membranes to reduce pain. These products provide targeted relief by delivering active ingredients to the specific area of pain or inflammation. They are commonly used for muscle aches, joint pain, arthritis, and injuries.
The main categories of topical pain relief include prescription pain relief and over-the-counter (OTC) pain relief. Prescription pain relief consists of medications or treatments that require a healthcare professional’s authorization. These are available in various forms, including creams, gels, sprays, patches, and more. They are used in both non-opioid and opioid therapies and are distributed through pharmacies, drug stores, e-commerce platforms, retail outlets, and grocery stores.
The topical pain relief market consists of sales of such as lotions, instant relief creams, roll-ons, pumps of lotion, analgesic creams, powders and rubs. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Topical Pain Relief Market Characteristics
3. Topical Pain Relief Market Supply Chain Analysis
4. Global Topical Pain Relief Market Trends and Strategies
5. Topical Pain Relief Market Analysis of End Use Industries
7. Global Topical Pain Relief Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Topical Pain Relief Total Addressable Market (TAM) Analysis for the Market
9. Topical Pain Relief Market Segmentation
10. Topical Pain Relief Market Regional and Country Analysis
11. Asia-Pacific Topical Pain Relief Market
12. China Topical Pain Relief Market
13. India Topical Pain Relief Market
14. Japan Topical Pain Relief Market
15. Australia Topical Pain Relief Market
16. Indonesia Topical Pain Relief Market
17. South Korea Topical Pain Relief Market
18. Taiwan Topical Pain Relief Market
19. South East Asia Topical Pain Relief Market
20. Western Europe Topical Pain Relief Market
21. UK Topical Pain Relief Market
22. Germany Topical Pain Relief Market
23. France Topical Pain Relief Market
24. Italy Topical Pain Relief Market
25. Spain Topical Pain Relief Market
26. Eastern Europe Topical Pain Relief Market
27. Russia Topical Pain Relief Market
28. North America Topical Pain Relief Market
29. USA Topical Pain Relief Market
30. Canada Topical Pain Relief Market
31. South America Topical Pain Relief Market
32. Brazil Topical Pain Relief Market
33. Middle East Topical Pain Relief Market
34. Africa Topical Pain Relief Market
36. Topical Pain Relief Market Competitive Landscape and Company Profiles
37. Topical Pain Relief Market Other Major and Innovative Companies
40. Topical Pain Relief Market High Potential Countries, Segments and Strategies
41. Appendix
Executive Summary
Topical Pain Relief Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses topical pain relief market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for topical pain relief? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The topical pain relief market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Prescription Pain Relief; Over-The-Counter (OTC) Pain Relief2) By Formulation: Cream; Gel; Spray; Patch; Other Formulations
3) By Therapeutic: Non-Opioids; Opioids
4) By Distribution Channel: Pharmacies And Drug Stores; E-Commerce; Retail And Grocery Stores
Subsegments:
1) By Prescription Pain Relief: Prescription Creams And Gels; Prescription Patches; Compounded Topical Analgesics2) By Over-The-Counter (OTC) Pain Relief: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs); Counterirritants; Analgesic Creams And Gels
Companies Mentioned: Pfizer Inc.; Johnson & Johnson; AbbVie Inc.; Bayer AG; Novartis AG; Sanofi S.A.; GlaxoSmithKline Plc; Eli Lilly and Company; Reckitt Benckiser Group plc; Viatris Inc.; Teva Pharmaceutical Industries Ltd.; Mylan N.V.; Sun Pharmaceutical Industries Ltd.; Perrigo Company PLC; Dr. Reddy's Laboratories Ltd.; Aurobindo Pharma Limited; Cipla Ltd.; Lupin Limited; Almirall S.A.; AdvaCare Pharma; Topical BioMedics Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Topical Pain Relief market report include:- Pfizer Inc.
- Johnson & Johnson
- AbbVie Inc.
- Bayer AG
- Novartis AG
- Sanofi S.A.
- GlaxoSmithKline Plc
- Eli Lilly and Company
- Reckitt Benckiser Group plc
- Viatris Inc.
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V.
- Sun Pharmaceutical Industries Ltd.
- Perrigo Company PLC
- Dr. Reddy's Laboratories Ltd.
- Aurobindo Pharma Limited
- Cipla Ltd.
- Lupin Limited
- Almirall S.A.
- AdvaCare Pharma
- Topical BioMedics Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 12.04 Billion |
| Forecasted Market Value ( USD | $ 14.88 Billion |
| Compound Annual Growth Rate | 5.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
